|
|
Volumn 4, Issue 1, 2007, Pages 16-17
|
|
Can lipid-lowering medication reduce the prevalence of atrial fibrillation in patients with left ventricular dysfunction?: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIARRHYTHMIC AGENT;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BILE ACID SEQUESTRANT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
NICOTINIC ACID;
PLACEBO;
COMORBIDITY;
ELECTROCARDIOGRAPHY;
HEART ATRIUM FIBRILLATION;
HEART LEFT VENTRICLE CONTRACTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FAILURE;
HEART RHYTHM;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
INTERVIEW;
ISCHEMIC HEART DISEASE;
MEDICAL RECORD REVIEW;
MEDICAL RESEARCH;
METHODOLOGY;
OBSERVATIONAL STUDY;
OUTCOME ASSESSMENT;
PRESCRIPTION;
PREVALENCE;
PRIORITY JOURNAL;
RESEARCH SUBJECT;
RISK FACTOR;
RISK REDUCTION;
SHORT SURVEY;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 33845762318
PISSN: 17434297
EISSN: 17434300
Source Type: Journal
DOI: 10.1038/ncpcardio0724 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (5)
|
